Domestic and globally-based pharmaceutical and life sciences companies face unique issues under tax reform proposals currently making headway through the legislative process. PwC’s Pharmaceutical and Life Sciences Tax Sector Leader, Kathy Michael, and PwC’s New York Metro Pharmaceutical and Life Sciences Leader, Ben Proce, discuss what’s top of mind for companies in the pharma and life sciences industry.